Complete Filing Data
CORCEPT THERAPEUTICS INC reported Net Income Loss of $99.65 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean CORCEPT THERAPEUTICS INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 | FY2002 | FY2001 | FY2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $99.7M | $141.2M | $106.1M | $101.4M | $112.5M | $106.0M | $94.2M | $75.4M | $129.1M | $8.1M | -$6.4M | -$31.4M | -$46.0M | -$38.0M | -$32.4M | -$26.0M | -$20.2M | -$20.1M | -$11.6M | -$24.9M | -$20.1M | -$15.5M | -$9.8M | -$18.5M | -$7.5M | -$1.8M |
| Cost of Revenue * | $13.0M | $10.9M | $6.5M | $5.4M | $5.3M | $5.6M | $5.5M | $5.2M | $3.6M | $2.1M | $1.4M | $882.0K | $143.0K | $91.0K | ||||||||||||
| Revenue * | $761.4M | $675.0M | $482.4M | $401.9M | $366.0M | $353.9M | $306.5M | $251.2M | $159.2M | $81.3M | $50.3M | $26.6M | $10.4M | $3.3M | $29.0K | |||||||||||
| Research And Development Expense | $254.9M | $246.9M | $184.4M | $131.0M | $113.9M | $114.8M | $89.0M | $75.2M | $40.4M | $23.8M | $15.4M | $18.4M | $20.5M | $14.1M | $21.0M | $18.9M | $14.4M | |||||||||
| Operating Income Loss | $44.8M | $137.0M | $107.3M | $112.6M | $124.5M | $128.2M | $111.6M | $89.5M | $52.9M | $10.2M | -$3.4M | -$27.6M | -$41.5M | -$36.3M | -$32.3M | -$27.4M | -$20.3M | |||||||||
| Selling General And Administrative Expense | $448.7M | $280.3M | $184.3M | $152.8M | $122.4M | $105.3M | $100.4M | $81.3M | $62.4M | $45.2M | $36.9M | $34.9M | $31.2M | $25.4M | $11.3M | $8.5M | ||||||||||
| Comprehensive Income Net Of Tax | $102.1M | $140.4M | $107.6M | $100.8M | $111.9M | $106.2M | $94.5M | $75.4M | $129.0M | $8.1M | -$6.4M | -$31.4M | -$46.0M | -$38.0M | -$32.4M | -$26.0M | -$20.2M | -$20.1M | -$11.6M | -$24.8M | -$20.1M | -$15.6M | -$9.8M | |||
| Income Tax Expense Benefit | -$33.2M | $20.3M | $18.4M | $14.8M | $12.5M | $25.6M | $22.5M | $16.7M | -$76.3M | $0.00 | $0.00 | |||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | -$308.0K | $118.0K | -$353.0K | $105.0K | $198.0K | -$15.0K | -$104.0K | $22.0K | $0.00 | $0.00 | ||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $1.4M | -$228.0K | $358.0K | -$311.0K | -$21.0K | $204.0K | $4.0K | $0.00 | ||||||||||||||||||
| Nonoperating Income Expense | $21.7M | $24.5M | $17.3M | $3.6M | $529.0K | |||||||||||||||||||||
| Deferred Income Tax Expense Benefit | -$37.5M | -$40.2M | -$29.5M | -$33.9M | $4.3M | $14.1M | $16.9M | $14.1M | -$76.7M | $0.00 | $0.00 | |||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $327.0K | $5.0K | -$75.0K | $0.00 | $0.00 | |||||||||||||||||||||
| Operating Expenses | $54.2M | $51.9M | $39.6M | $32.3M | $27.4M | $20.3M | ||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $66.5M | $161.5M | $124.6M | $116.2M | $125.0M | $131.6M | $116.7M | |||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $131.6M | $116.7M | $92.2M | $52.8M | $8.1M | -$6.4M | ||||||||||||||||||||
| Deferred Income Tax Assets Net | $168.2M | $130.9M | $90.6M | $61.5M | $27.5M | $31.6M | $45.7M | $62.7M | $76.7M | |||||||||||||||||
| Accrued Income Taxes Noncurrent | $15.2M | $14.1M | $10.3M | $9.1M | $409.0K | $398.0K | $386.0K | $239.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $19.7M | $35.1M | $20.5M | $47.2M | $35.5M | $27.8M | $31.4M | $27.5M | $15.9M | $34.6M | $27.4M | $22.8M | $30.5M | $26.5M | $23.5M | $26.0M | $21.6M | $28.3M | $30.1M | $29.4M | $26.3M | $20.2M | $18.3M | $22.0M | $17.7M | $18.2M | $17.5M | $98.3M | $13.8M | $12.6M | $4.4M | $4.6M | $2.6M | $977.0K | -$19.0K | $959.0K | -$601.0K | -$1.9M | -$4.8M | -$3.9M | -$6.0M | -$7.6M | -$13.9M | -$11.1M | -$10.9M | -$11.9M | -$12.1M | -$11.1M | -$8.3M | -$7.6M | -$11.0M | -$9.9M | -$6.4M | -$8.9M | -$7.1M | -$7.1M | -$5.7M |
| Cost of Revenue * | $4.6M | $3.4M | $2.4M | $2.9M | $2.5M | $2.5M | $1.6M | $1.6M | $1.4M | $1.3M | $1.3M | $1.3M | $1.3M | $1.4M | $1.3M | $1.2M | $1.2M | $1.9M | $1.5M | $1.4M | $1.2M | $1.3M | $1.2M | $1.2M | $976.0K | $775.0K | $646.0K | $668.0K | $426.0K | $403.0K | $256.0K | $439.0K | $302.0K | $235.0K | $215.0K | $174.0K | $40.0K | $23.0K | $20.0K | $24.0K | $48.0K | ||||||||||||||||
| Revenue * | $207.6M | $194.4M | $157.2M | $182.5M | $163.8M | $146.8M | $123.6M | $117.7M | $105.7M | $101.7M | $103.4M | $93.7M | $96.1M | $91.6M | $79.4M | $85.7M | $86.3M | $88.6M | $93.2M | $87.9M | $81.5M | $72.3M | $64.8M | $66.8M | $64.4M | $62.3M | $57.7M | $53.3M | $42.8M | $35.6M | $27.6M | $23.8M | $21.7M | $19.7M | $16.1M | $15.0M | $13.3M | $12.0M | $10.1M | $9.0M | $7.3M | $5.9M | $4.4M | $4.1M | $2.6M | $1.9M | $1.7M | $1.4M | $1.1M | $875.0K | |||||||
| Research And Development Expense | $68.8M | $60.5M | $60.7M | $59.3M | $58.7M | $58.5M | $45.5M | $43.3M | $40.9M | $33.3M | $32.8M | $28.1M | $28.1M | $28.2M | $29.0M | $33.9M | $26.5M | $26.1M | $22.8M | $21.7M | $20.2M | $18.9M | $20.5M | $17.1M | $11.7M | $7.9M | $7.2M | $7.1M | $5.7M | $4.6M | $3.6M | $3.3M | $4.4M | $3.0M | $4.3M | $7.3M | $5.2M | $4.5M | $4.3M | $3.0M | $2.7M | $3.5M | $3.2M | $6.2M | $4.9M | $5.2M | $4.6M | ||||||||||
| Operating Income Loss | $10.2M | $26.7M | $3.4M | $46.6M | $35.6M | $29.5M | $31.2M | $29.6M | $14.9M | $31.9M | $31.4M | $26.8M | $36.2M | $31.9M | $19.6M | $24.7M | $35.3M | $37.7M | $33.0M | $24.6M | $19.0M | $23.0M | $20.6M | $21.0M | $13.6M | $12.8M | $4.7M | $3.1M | $1.5M | $592.0K | $102.0K | -$1.2M | -$4.0M | -$5.1M | -$6.6M | -$12.9M | -$9.7M | -$10.8M | -$10.9M | -$7.7M | -$7.6M | -$11.0M | -$6.4M | -$8.9M | -$7.1M | -$7.1M | -$6.4M | ||||||||||
| Selling General And Administrative Expense | $124.0M | $103.9M | $90.7M | $73.7M | $66.9M | $56.3M | $45.3M | $43.3M | $48.6M | $35.2M | $37.8M | $37.5M | $30.5M | $30.0M | $29.5M | $26.5M | $25.6M | $27.5M | $24.2M | $24.6M | $24.4M | $21.3M | $20.0M | $18.4M | $16.5M | $14.1M | $15.0M | $10.9M | $12.1M | $10.4M | $9.3M | $9.3M | $9.5M | $9.1M | $8.0M | $9.8M | $7.2M | $8.2M | $8.4M | $5.7M | $5.8M | $7.5M | $3.2M | $2.7M | $2.2M | ||||||||||||
| Comprehensive Income Net Of Tax | $19.7M | $36.7M | $21.5M | $48.7M | $35.3M | $27.4M | $31.1M | $27.7M | $16.6M | $34.4M | $26.6M | $21.7M | $30.4M | $26.5M | $23.3M | $21.4M | $28.9M | $30.1M | $26.3M | $20.4M | $18.4M | $17.8M | $18.2M | $17.3M | $13.8M | $12.6M | $4.4M | $2.6M | $977.0K | -$19.0K | |||||||||||||||||||||||||||
| Income Tax Expense Benefit | -$4.4M | -$3.5M | -$10.9M | $5.7M | $6.1M | $7.2M | $5.0M | $5.4M | $2.6M | -$1.6M | $4.7M | $4.1M | $5.8M | $5.5M | -$3.6M | $3.7M | $7.9M | $9.1M | $8.0M | $5.6M | $1.8M | $6.0M | $3.0M | $3.8M | -$48.0K | $50.0K | $127.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | -$116.0K | $21.0K | -$175.0K | -$256.0K | $14.0K | $103.0K | $31.0K | -$23.0K | -$192.0K | $23.0K | -$149.0K | -$323.0K | -$8.0K | $16.0K | $61.0K | $109.0K | -$170.0K | -$20.0K | $1.0K | -$73.0K | -$52.0K | -$16.0K | -$7.0K | $48.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$320.0K | $1.4M | $358.0K | $536.0K | $15.0K | -$21.0K | -$184.0K | $123.0K | $111.0K | -$314.0K | -$320.0K | -$105.0K | -$77.0K | $16.0K | $26.0K | $84.0K | -$15.0K | -$12.0K | -$5.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||
| Nonoperating Income Expense | $5.0M | $5.0M | $6.2M | $6.3M | $6.0M | $5.5M | $5.2M | $3.3M | $3.6M | $1.1M | $630.0K | $80.0K | $72.0K | $110.0K | $275.0K | $622.0K | $1.0M | $1.5M | $1.3M | $1.2M | $1.1M | $759.0K | $562.0K | ||||||||||||||||||||||||||||||||||
| Deferred Income Tax Expense Benefit | -$13.7M | -$7.2M | -$6.7M | -$9.9M | -$5.4M | $5.1M | $926.0K | $3.2M | $0.00 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$1.0M | -$23.0K | -$50.0K | -$192.0K | -$347.0K | $545.0K | $61.0K | -$2.0K | $227.0K | $164.0K | $50.0K | $25.0K | -$152.0K | $3.0K | -$5.0K | -$12.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||||
| Operating Expenses | $13.2M | $13.1M | $14.1M | $12.4M | $12.4M | $17.3M | $12.4M | $12.7M | $12.7M | $8.7M | $8.5M | $11.0M | $6.4M | $8.9M | $7.1M | $7.1M | $6.4M | ||||||||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $15.2M | $31.7M | $9.6M | $52.9M | $41.6M | $35.0M | $36.4M | $32.9M | $18.4M | $33.0M | $32.1M | $26.8M | $36.3M | $32.1M | $19.9M | $25.3M | |||||||||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $32.1M | $19.9M | $25.3M | $36.3M | $39.2M | $34.4M | $25.8M | $20.1M | $23.7M | $21.2M | $21.3M | $13.7M | $12.7M | $4.5M | $2.6M | $977.0K | -$19.0K | ||||||||||||||||||||||||||||||||||||||||
| Deferred Income Tax Assets Net | $153.0M | $162.2M | $144.4M | $126.8M | $111.8M | $97.9M | $87.1M | $78.2M | $68.0M | $57.3M | $48.5M | $37.7M | $29.6M | $33.7M | $37.0M | $33.8M | $35.5M | $40.6M | $50.8M | $56.7M | $61.7M | ||||||||||||||||||||||||||||||||||||
| Accrued Income Taxes Noncurrent | $14.1M | $15.7M | $14.3M | $12.8M | $11.9M | $10.9M | $10.5M | $10.0M | $9.4M | $6.8M | $5.0M | $2.5M | $413.0K | $403.0K | $995.0K | $400.0K | $396.0K | $389.0K | $250.0K | $245.0K | $239.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 | FY2002 | FY2001 | FY2000 | FY1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $647.8M | $679.6M | $506.7M | $501.8M | $375.8M | $523.3M | $371.2M | $275.9M | $191.0M | $41.4M | $18.5M | -$3.4M | $21.0M | $61.8M | $34.8M | $21.2M | $22.1M | $16.9M | $14.7M | $6.4M | $26.6M | $45.9M | -$31.5M | -$21.9M | -$7.5M | -$2.0M | -$244.0K |
| Cash And Cash Equivalents At Carrying Value | $120.5M | $127.7M | $135.6M | $66.3M | $77.6M | $76.2M | $31.3M | $41.6M | $31.1M | $51.5M | $40.4M | $24.2M | $54.9M | $93.0M | $39.6M | $24.6M | $23.9M | $14.7M | |||||||||
| Property Plant And Equipment Net | $1.9M | $2.7M | $195.0K | $633.0K | $1.0M | $1.7M | $1.1M | $655.0K | $518.0K | $205.0K | $98.0K | $236.0K | $203.0K | $150.0K | $26.0K | $4.0K | |||||||||||
| Prepaid Expense And Other Assets Current | $40.7M | $21.9M | $27.6M | $16.4M | $10.3M | $6.7M | $6.0M | $7.7M | $2.7M | $2.0M | $642.0K | $1.4M | $910.0K | $620.0K | $140.0K | $418.0K | |||||||||||
| Other Assets Noncurrent | $5.2M | $6.6M | $6.5M | $5.1M | $3.1M | $5.0M | $3.4M | $50.0K | $50.0K | $24.0K | $24.0K | $74.0K | $113.0K | $144.0K | $32.0K | $104.0K | |||||||||||
| Liabilities Current | $166.1M | $140.8M | $104.5M | $72.5M | $47.5M | $47.5M | $38.8M | $35.6M | $29.6M | $27.4M | $20.9M | $13.6M | $12.7M | $8.4M | $5.0M | $3.9M | |||||||||||
| Liabilities And Stockholders Equity | $836.7M | $840.6M | $621.5M | $583.4M | $423.8M | $571.7M | $412.3M | $311.7M | $220.5M | $68.8M | $51.9M | $34.6M | $63.1M | $99.2M | $39.8M | $25.1M | |||||||||||
| Assets Current | $485.5M | $471.6M | $458.6M | $499.3M | $266.5M | $478.5M | $307.4M | $236.8M | $124.2M | $65.7M | $49.0M | $30.2M | $58.3M | $95.1M | $39.8M | $25.0M | |||||||||||
| Assets | $836.7M | $840.6M | $621.5M | $583.4M | $423.8M | $571.7M | $412.3M | $311.7M | $220.5M | $68.8M | $51.9M | $34.6M | $63.1M | $99.2M | $39.8M | $25.1M | |||||||||||
| Accrued Liabilities Current | $90.6M | $90.7M | $51.6M | $30.8M | $27.7M | $21.2M | $23.3M | $23.8M | $18.7M | $9.0M | $3.3M | $1.9M | $1.3M | $1.0M | $533.0K | $815.0K | |||||||||||
| Accounts Payable Current | $40.4M | $15.4M | $17.4M | $12.0M | $6.9M | $10.6M | $7.5M | $8.3M | $8.6M | $2.3M | $1.3M | $1.9M | $2.4M | $3.8M | $3.6M | $817.0K | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $120.5M | $127.7M | $135.6M | $66.3M | $77.6M | $76.2M | $31.3M | $41.6M | $31.1M | ||||||||||||||||||
| Retained Earnings Accumulated Deficit | $643.4M | $543.7M | $402.5M | $296.4M | $195.0M | $82.5M | -$23.6M | -$117.7M | -$193.1M | -$322.3M | -$330.4M | -$324.0M | -$292.6M | -$246.6M | -$176.2M | ||||||||||||
| Common Stock Value | $140.0K | $136.0K | $127.0K | $122.0K | $120.0K | $117.0K | $115.0K | $113.0K | $110.0K | $101.0K | $100.0K | $100.0K | $84.0K | $72.0K | |||||||||||||
| Inventory Net | $12.9M | $12.4M | $7.7M | $6.1M | $5.0M | $4.9M | $5.4M | $4.7M | $4.6M | $2.3M | $1.7M | $1.2M | $1.1M | $853.0K | |||||||||||||
| Accounts Receivable Net Current | $59.8M | $54.0M | $41.1M | $31.1M | $27.6M | $26.2M | $19.9M | $17.6M | $15.3M | $9.9M | $6.2M | $3.3M | $1.4M | $557.0K | |||||||||||||
| Accrued Clinical Expenses Current | $13.7M | $6.5M | $3.5M | $2.2M | $1.5M | $1.2M | $336.0K | $3.3M | $843.0K | $644.0K | |||||||||||||||||
| Inventory Noncurrent | $11.1M | $3.6M | $8.2M | $10.9M | $13.0M | $16.2M | $12.0M | $11.5M | $3.8M | $2.8M | $2.8M | ||||||||||||||||
| Marketable Securities Unrealized Gain Loss | $5.0K | -$75.0K | |||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$10.4M | $10.6M | -$20.5M | $11.1M | $16.2M | -$30.6M | -$38.2M | $53.4M | $15.1M | $711.0K | $9.2M | ||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.3M | -$217.0K | $609.0K | -$869.0K | -$227.0K | $415.0K | $261.0K | -$70.0K | -$75.0K | $0.00 | |||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$7.2M | -$7.9M | $69.2M | -$11.3M | $1.4M | $44.9M | -$10.4M | $10.6M | |||||||||||||||||||
| Shares Repurchased In Net Settlement Of Cashless Option Exercise | 24.6M | 21.2M | 25.0M | 24.4M | 15.8M | 2.1M | 2.0M | 0.00 | 0.00 | ||||||||||||||||||
| Marketable Securities Noncurrent | $160.3M | $219.8M | $57.2M | $4.9M | $0.00 | ||||||||||||||||||||||
| Marketable Securities Current | $251.7M | $255.7M | $232.7M | $365.3M | $0.00 | ||||||||||||||||||||||
| Liabilities | $188.8M | $161.0M | $114.8M | $81.6M | $48.0M | $48.4M | $41.1M | $35.8M | $29.6M | ||||||||||||||||||
| Interest And Debt Expense | $2.0M | $3.0M | $3.8M | $4.5M | $1.8M | $25.0K | |||||||||||||||||||||
| Treasury Stock Common Value | $966.6M | $696.2M | $635.1M | $456.1M | $410.4M | $75.8M | $62.7M | $23.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $631.9M | $635.8M | $683.3M | $638.8M | $596.2M | $547.9M | $461.7M | $421.6M | $529.6M | $473.4M | $442.3M | $407.8M | $540.2M | $522.7M | $510.8M | $489.7M | $453.7M | $409.5M | $334.4M | $298.1M | $285.8M | $259.5M | $243.5M | $215.2M | $86.3M | $66.1M | $49.6M | $31.2M | $25.7M | $20.2M | $13.5M | $11.5M | $10.6M | -$1.3M | $3.5M | $9.4M | $30.8M | $40.4M | $51.0M | $71.7M | $32.8M | $39.3M | $43.7M | $48.9M | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | $125.1M | $102.7M | $89.8M | $137.3M | $128.6M | $149.8M | $111.8M | $172.4M | $299.9M | $35.3M | $61.9M | $94.7M | $95.4M | $52.4M | $30.6M | $58.5M | $84.5M | $44.9M | $58.1M | $49.7M | $33.9M | $31.2M | $33.1M | $31.1M | $33.6M | $38.0M | $47.9M | $41.8M | $40.7M | $36.5M | $37.0M | $38.0M | $26.8M | $34.0M | $43.6M | $63.2M | $72.2M | $81.5M | $101.6M | $34.9M | $42.6M | $45.9M | $52.2M | $59.2M | $29.0M | $35.4M | |||||||||||
| Property Plant And Equipment Net | $2.1M | $2.3M | $2.5M | $2.9M | $1.5M | $127.0K | $302.0K | $413.0K | $461.0K | $801.0K | $862.0K | $726.0K | $1.2M | $1.4M | $1.5M | $1.3M | $619.0K | $880.0K | $1.2M | $1.2M | $925.0K | $540.0K | $552.0K | $577.0K | $553.0K | $499.0K | $302.0K | $145.0K | $76.0K | $93.0K | $143.0K | $173.0K | $230.0K | $273.0K | $296.0K | $285.0K | $184.0K | $139.0K | $154.0K | $105.0K | $59.0K | $30.0K | $3.0K | $3.0K | |||||||||||||
| Prepaid Expense And Other Assets Current | $37.5M | $24.0M | $39.6M | $18.9M | $25.5M | $23.9M | $20.2M | $15.9M | $15.9M | $20.7M | $15.4M | $10.4M | $9.1M | $9.0M | $9.5M | $7.9M | $5.3M | $5.7M | $7.8M | $6.2M | $5.7M | $4.3M | $3.6M | $3.3M | $3.1M | $2.5M | $1.8M | $1.4M | $1.6M | $1.1M | $1.2M | $1.2M | $622.0K | $1.8M | $2.2M | $1.5M | $1.0M | $801.0K | $572.0K | $800.0K | $608.0K | $102.0K | $427.0K | $455.0K | |||||||||||||
| Other Assets Noncurrent | $8.0M | $8.3M | $6.6M | $7.0M | $6.9M | $6.4M | $6.5M | $4.4M | $4.8M | $5.1M | $1.8M | $3.0M | $4.1M | $4.1M | $5.0M | $5.0M | $4.5M | $3.4M | $150.0K | $150.0K | $75.0K | $53.0K | $53.0K | $73.0K | $13.0M | $49.0K | $49.0K | $24.0K | $24.0K | $25.0K | $65.0K | $71.0K | $78.0K | $81.0K | $87.0K | $96.0K | $120.0K | $128.0K | $136.0K | $160.0K | $260.0K | $72.0K | $40.0K | $32.0K | |||||||||||||
| Liabilities Current | $172.3M | $144.7M | $143.1M | $126.2M | $100.8M | $97.2M | $121.9M | $93.1M | $78.9M | $53.1M | $49.1M | $57.2M | $44.8M | $45.4M | $40.6M | $43.0M | $42.2M | $34.1M | $32.4M | $30.4M | $34.2M | $40.2M | $30.9M | $27.7M | $24.4M | $20.4M | $25.8M | $31.7M | $27.4M | $24.0M | $18.8M | $17.4M | $15.5M | $12.5M | $13.3M | $15.2M | $10.1M | $9.1M | $8.2M | $5.5M | $5.8M | $3.6M | $2.7M | $3.9M | |||||||||||||
| Liabilities And Stockholders Equity | $823.6M | $801.7M | $846.5M | $784.3M | $714.6M | $655.9M | $594.0M | $524.6M | $617.8M | $533.3M | $496.4M | $468.1M | $585.4M | $568.5M | $552.4M | $534.1M | $497.8M | $445.5M | $367.0M | $328.7M | $320.2M | $299.8M | $274.4M | $243.0M | $110.7M | $86.5M | $75.3M | $62.9M | $56.8M | $52.9M | $48.4M | $48.4M | $48.2M | $37.2M | $44.4M | $52.8M | $71.1M | $79.7M | $88.1M | $105.5M | $38.6M | $42.9M | $46.4M | $52.7M | |||||||||||||
| Assets Current | $541.1M | $443.1M | $438.5M | $467.0M | $560.8M | $503.4M | $431.5M | $432.6M | $533.9M | $452.4M | $419.0M | $388.2M | $401.9M | $411.3M | $409.6M | $463.5M | $438.3M | $344.8M | $267.3M | $232.7M | $216.9M | $224.2M | $197.2M | $150.8M | $93.9M | $81.3M | $66.7M | $59.8M | $54.8M | $50.5M | $45.2M | $44.7M | $44.2M | $32.4M | $39.4M | $48.1M | $66.2M | $74.6M | $84.2M | $104.6M | $38.3M | $42.8M | $46.3M | $52.7M | |||||||||||||
| Assets | $823.6M | $801.7M | $846.5M | $784.3M | $714.6M | $655.9M | $594.0M | $524.6M | $617.8M | $533.3M | $496.4M | $468.1M | $585.4M | $568.5M | $552.4M | $534.1M | $497.8M | $445.5M | $367.0M | $328.7M | $320.2M | $299.8M | $274.4M | $243.0M | $110.7M | $86.5M | $75.3M | $62.9M | $56.8M | $52.9M | $48.4M | $48.4M | $48.2M | $37.2M | $44.4M | $52.8M | $71.1M | $79.7M | $88.1M | $105.5M | $38.6M | $42.9M | $46.4M | $52.7M | |||||||||||||
| Accrued Liabilities Current | $108.4M | $91.1M | $88.9M | $79.5M | $59.3M | $59.7M | $69.6M | $52.2M | $39.1M | $29.4M | $24.7M | $32.7M | $24.3M | $21.5M | $18.0M | $19.0M | $22.6M | $19.6M | $21.6M | $16.4M | $18.8M | $20.9M | $19.1M | $16.4M | $16.3M | $12.2M | $9.9M | $6.9M | $5.8M | $4.5M | $2.8M | $2.5M | $2.4M | $1.5M | $1.6M | $1.3M | $777.0K | $812.0K | $958.0K | $786.0K | $640.0K | $781.0K | $755.0K | $799.0K | |||||||||||||
| Accounts Payable Current | $34.4M | $23.5M | $27.9M | $18.6M | $19.5M | $12.6M | $16.7M | $8.0M | $11.2M | $8.2M | $8.2M | $9.3M | $6.6M | $9.2M | $7.0M | $6.5M | $6.3M | $5.0M | $5.9M | $7.0M | $9.3M | $13.9M | $6.4M | $7.9M | $6.2M | $2.1M | $4.3M | $4.3M | $2.1M | $2.1M | $1.7M | $2.4M | $1.0M | $2.0M | $2.6M | $3.7M | $2.3M | $3.0M | $2.3M | $1.6M | $4.2M | $2.1M | $1.1M | $2.3M | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $125.1M | $102.7M | $89.8M | $137.3M | $128.6M | $149.8M | $111.8M | $172.4M | $299.9M | $50.2M | $35.3M | $61.9M | $94.7M | $95.4M | $52.4M | $30.6M | $58.5M | $84.5M | $44.9M | $58.1M | $49.7M | $33.9M | $31.2M | $33.1M | $31.1M | $33.6M | $51.5M | ||||||||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | $619.1M | $599.4M | $564.3M | $513.0M | $465.8M | $430.3M | $371.2M | $339.8M | $312.3M | $279.8M | $245.2M | $217.8M | $162.9M | $132.4M | $105.9M | $56.5M | $34.8M | $6.5M | -$52.9M | -$79.3M | -$99.5M | -$139.7M | -$157.5M | -$175.7M | -$291.5M | -$305.2M | -$317.9M | -$326.9M | -$329.5M | -$330.4M | -$331.4M | -$330.8M | -$328.8M | -$320.1M | -$314.1M | -$306.5M | -$281.5M | -$270.6M | -$258.7M | -$219.6M | -$208.6M | -$198.6M | -$192.2M | ||||||||||||||
| Common Stock Value | $139.0K | $138.0K | $135.0K | $134.0K | $133.0K | $133.0K | $132.0K | $131.0K | $131.0K | $130.0K | $128.0K | $128.0K | $126.0K | $125.0K | $124.0K | $121.0K | $121.0K | $120.0K | $119.0K | $118.0K | $118.0K | $116.0K | $116.0K | $115.0K | $114.0K | $113.0K | $113.0K | $111.0K | $110.0K | $110.0K | $109.0K | $108.0K | $108.0K | $101.0K | $101.0K | $101.0K | $100.0K | $100.0K | $100.0K | $100.0K | $89.0K | $89.0K | $84.0K | $84.0K | |||||||||||||
| Inventory Net | $12.3M | $12.3M | $14.4M | $8.1M | $8.4M | $7.2M | $7.5M | $6.9M | $6.4M | $6.0M | $5.4M | $5.1M | $5.0M | $4.7M | $4.9M | $4.8M | $4.9M | $5.1M | $5.5M | $5.1M | $5.0M | $5.4M | $4.9M | $4.9M | $3.8M | $3.1M | $2.9M | $2.3M | $2.1M | $1.9M | $1.6M | $1.5M | $1.3M | $1.1M | $1.1M | $1.1M | $1.0M | $694.0K | $1.0M | $1.8M | $2.4M | $56.0K | |||||||||||||||
| Accounts Receivable Net Current | $69.6M | $64.6M | $61.8M | $59.7M | $53.8M | $61.5M | $34.6M | $32.6M | $32.6M | $29.4M | $28.2M | $27.2M | $26.5M | $27.6M | $22.2M | $22.0M | $22.7M | $26.7M | $22.4M | $19.8M | $19.2M | $19.4M | $28.7M | $17.3M | $11.9M | $9.5M | $9.2M | $8.2M | $9.3M | $6.8M | $5.9M | $5.0M | $4.3M | $2.7M | $2.2M | $1.9M | $1.0M | $855.0K | $1.1M | $354.0K | $355.0K | ||||||||||||||||
| Accrued Clinical Expenses Current | $25.3M | $33.9M | $24.8M | $21.3M | $14.0M | $14.6M | $13.8M | $13.1M | $12.4M | $12.8M | $13.1M | $13.6M | $15.5M | $11.3M | $7.9M | $4.1M | $5.8M | $4.5M | $5.4M | $5.4M | $3.5M | $1.9M | $1.5M | $1.5M | $1.8M | $963.0K | $1.1M | $609.0K | $492.0K | $1.4M | $276.0K | $1.6M | $3.4M | $2.0M | $1.0M | $583.0K | $605.0K | ||||||||||||||||||||
| Inventory Noncurrent | $12.0M | $8.0M | $1.2M | $7.8M | $8.5M | $7.8M | $8.8M | $8.8M | $10.2M | $11.0M | $12.0M | $13.1M | $13.7M | $14.7M | $15.4M | $12.1M | $11.2M | $11.1M | $11.5M | $12.7M | $10.4M | $7.4M | $5.5M | $2.9M | $1.7M | $3.2M | $3.8M | $3.0M | $2.0M | $2.3M | |||||||||||||||||||||||||||
| Marketable Securities Unrealized Gain Loss | $50.0K | $1.6M | $909.0K | $1.5M | -$174.0K | -$351.0K | -$279.0K | $198.0K | $716.0K | -$240.0K | -$790.0K | -$1.1M | -$100.0K | -$34.0K | -$166.0K | -$263.0K | $530.0K | $49.0K | -$7.0K | $227.0K | $164.0K | $51.0K | $24.0K | -$77.0K | |||||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $2.1M | -$13.6M | $309.0K | $13.7M | -$11.3M | -$11.6M | $3.0M | $34.6M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.3M | $2.3M | $692.0K | $1.6M | $84.0K | $258.0K | -$234.0K | $45.0K | -$153.0K | -$2.4M | -$2.1M | -$1.4M | $115.0K | $215.0K | $249.0K | $577.0K | $840.0K | $310.0K | $314.0K | $321.0K | $94.0K | -$77.0K | -$127.0K | -$152.0K | -$14.0K | -$17.0K | -$12.0K | ||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$37.8M | $14.2M | $233.6M | -$15.8M | -$23.8M | $53.2M | $8.0M | $2.1M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Shares Repurchased In Net Settlement Of Cashless Option Exercise | 5.3M | 1.8M | 5.2M | 5.1M | 6.0M | 0.00 | 931.0K | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Marketable Securities Noncurrent | $102.6M | $172.8M | $248.0M | $167.3M | $19.3M | $40.3M | $59.6M | $0.00 | $0.00 | $4.9M | $11.9M | $22.6M | $112.3M | $133.8M | $101.7M | $81.8M | $36.2M | $15.4M | $4.2M | $41.7M | $39.4M | $35.3M | $24.2M | $28.8M | $0.00 | $1.5M | $0.00 | $15.0M | $15.3M | $1.5M | $1.5M | $4.5M | |||||||||||||||||||||||||
| Marketable Securities Current | $296.5M | $239.5M | $232.9M | $243.0M | $344.6M | $261.0M | $243.4M | $190.9M | $165.1M | $346.0M | $334.7M | $283.7M | $145.9M | $266.6M | $274.6M | $320.6M | $364.5M | $398.2M | $346.8M | $222.8M | $244.7M | $186.7M | $143.4M | $137.3M | $165.1M | $161.3M | $128.8M | $92.2M | $57.7M | $44.1M | $32.5M | $14.8M | |||||||||||||||||||||||||
| Liabilities | $191.7M | $165.9M | $163.2M | $145.4M | $118.3M | $108.1M | $132.3M | $103.0M | $88.3M | $59.9M | $54.0M | $60.3M | $45.2M | $45.8M | $41.6M | $44.4M | $44.1M | $36.0M | $32.6M | $30.6M | $34.5M | ||||||||||||||||||||||||||||||||||||
| Interest And Debt Expense | $98.0K | $225.0K | $487.0K | $531.0K | $611.0K | $703.0K | $770.0K | $800.0K | $903.0K | $971.0K | $1.1M | $1.2M | $1.1M | $1.1M | $622.0K | $5.0K | $5.0K | ||||||||||||||||||||||||||||||||||||||||
| Treasury Stock Common Value | $923.3M | $866.9M | $744.7M | $682.2M | $650.8M | $641.1M | $631.8M | $614.1M | $462.5M | $453.0M | $426.8M | $417.4M | $194.3M | $164.3M | $131.9M | $64.0M | $63.8M | $63.0M | $59.7M | $59.7M | $42.3M | $8.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $84.5M | $61.4M | $48.9M | $42.4M | $42.9M | $33.5M | $29.3M | $23.7M | $13.4M | $7.1M | $6.0M | $5.2M | $5.2M | $5.3M | $3.4M | $2.1M | $1.8M |
| Financing Cash Flow * | -$220.4M | -$28.3M | -$148.7M | -$17.3M | -$302.6M | $12.2M | -$28.6M | -$14.3M | -$8.0M | -$7.1M | $13.1M | -$3.1M | -$970.0K | $89.6M | $42.5M | $23.0M | $23.5M |
| Investing Cash Flow * | $69.8M | -$177.6M | $90.9M | -$114.3M | $136.1M | -$119.3M | -$117.8M | -$90.8M | -$73.5M | -$194.0K | -$17.0K | -$174.0K | -$127.0K | -$151.0K | -$25.0K | $3.6M | |
| Operating Cash Flow * | $142.0M | $198.3M | $126.7M | $120.3M | $167.9M | $152.0M | $136.1M | $115.7M | $60.9M | $18.4M | $3.1M | -$27.4M | -$37.1M | -$36.0M | -$27.4M | -$22.3M | -$18.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $18.9M | -$5.4M | $11.6M | $6.6M | $4.0M | $653.0K | -$1.7M | $5.1M | $705.0K | $1.3M | -$799.0K | $531.0K | $290.0K | $480.0K | -$278.0K | -$135.0K | -$717.0K |
| Increase Decrease In Accounts Payable | $25.1M | -$2.0M | $5.4M | $4.8M | -$3.6M | $3.2M | -$735.0K | -$389.0K | $6.3M | $965.0K | -$561.0K | -$495.0K | -$1.4M | $193.0K | $2.8M | -$453.0K | -$34.0K |
| Depreciation Depletion And Amortization | $1.1M | $795.0K | $1.0M | $1.3M | $1.1M | $525.0K | $703.0K | $236.0K | $106.0K | $87.0K | $155.0K | $141.0K | $74.0K | $27.0K | $3.0K | $6.0K | $10.0K |
| Payments To Acquire Property Plant And Equipment | $211.0K | $2.2M | $139.0K | $413.0K | $469.0K | $1.2M | $1.1M | $298.0K | $419.0K | $194.0K | $17.0K | $174.0K | $127.0K | $151.0K | $25.0K | ||
| Increase Decrease In Other Operating Assets | -$1.5M | $69.0K | $1.5M | $2.0M | -$1.9M | $1.6M | $3.4M | $0.00 | $26.0K | $0.00 | $7.0K | -$10.0K | $4.0K | -$11.0K | -$72.0K | $23.0K | -$95.0K |
| Increase Decrease In Inventories | $7.5M | -$305.0K | -$1.3M | -$1.2M | -$3.4M | $3.5M | $1.0M | $7.8M | $2.3M | $682.0K | -$815.0K | -$249.0K | $883.0K | $4.7M | |||
| Increase Decrease In Accounts Receivable | $5.8M | $12.9M | $10.1M | $3.4M | $1.4M | $6.3M | $2.3M | $2.3M | $5.4M | $3.6M | $2.9M | $1.9M | $871.0K | $557.0K | |||
| Proceeds From Issuance Or Sale Of Equity | $5.8M | $4.4M | $16.2M | $23.2M | $8.4M | $9.3M | $7.2M | $7.7M | $17.1M | $55.0K | $59.4M | $42.5M | $23.0M | ||||
| Increase Decrease In Other Accrued Liabilities | $3.9M | $38.2M | $17.6M | $2.9M | $6.5M | -$2.1M | -$517.0K | $5.0M | $8.5M | $5.7M | $1.4M | $575.0K | |||||
| Adjustments Related To Tax Withholding For Share Based Compensation | $97.5M | $43.5M | $32.4M | $45.7M | $38.6M | $3.1M | $8.1M | ||||||||||
| Payments To Acquire Marketable Securities | $319.6M | $588.3M | $328.7M | $355.1M | $312.8M | $73.0M | $0.00 | $0.00 | |||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $72.9M | $22.3M | $9.1M | $21.7M | $22.8M | $1.1M | $6.1M | $0.00 | |||||||||
| Increase Decrease In Other Current Liabilities | -$1.3M | $7.2M | $3.0M | $1.3M | $780.0K | $296.0K | $835.0K | -$3.0M | $2.4M | $199.0K | -$171.0K | ||||||
| Increase Decrease In Operating Lease Liability | -$829.0K | $183.0K | -$1.3M | -$2.2M | -$2.0M | -$1.7M | -$1.5M | $0.00 | $0.00 | ||||||||
| Payments For Repurchase Of Common Stock | $172.9M | $15.7M | $0.00 | $0.00 | $9.9M | $31.0M | $23.7M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $21.8M | $13.2M | $11.1M | $10.8M | $10.1M | $7.9M | $6.7M | $5.0M | $2.7M | $1.6M | $1.4M | $1.4M | $1.3M | $2.4M | $954.0K | $869.0K | $580.0K | $545.0K | $502.0K | ||||||||||||
| Financing Cash Flow * | -$39.8M | -$543.0K | $181.0K | -$506.0K | -$45.9M | $205.0K | -$15.3M | $1.9M | -$3.7M | -$3.0M | $15.5M | -$89.0K | $13.2M | $41.9M | |||||||||||||||||
| Investing Cash Flow * | -$3.2M | -$9.0M | $207.5M | -$50.5M | -$3.3M | $19.7M | -$367.0K | -$34.3M | -$19.4M | -$22.0K | -$34.0K | -$110.0K | -$18.0K | -$7.0K | |||||||||||||||||
| Operating Cash Flow * | $5.1M | $23.8M | $26.0M | $35.2M | $25.4M | $33.3M | $23.7M | $34.4M | $9.6M | $3.3M | -$1.8M | -$11.1M | -$11.6M | -$10.2M | -$7.3M | ||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $13.5M | -$3.6M | -$729.0K | $9.0K | $2.9M | -$358.0K | -$2.0M | $635.0K | -$165.0K | $464.0K | -$819.0K | $543.0K | -$48.0K | -$38.0K | $186.0K | ||||||||||||||||
| Increase Decrease In Accounts Payable | $12.9M | -$4.9M | -$649.0K | $2.3M | -$3.5M | -$2.6M | $953.0K | -$759.0K | $2.0M | $757.0K | -$850.0K | $1.3M | -$1.5M | -$1.5M | $1.0M | ||||||||||||||||
| Depreciation Depletion And Amortization | $285.0K | $120.0K | $172.0K | $288.0K | $254.0K | $238.0K | $96.0K | $48.0K | $13.0K | $27.0K | $40.0K | $28.0K | $14.0K | $3.0K | |||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $104.0K | $0.00 | $0.00 | $12.0K | $126.0K | $42.0K | $257.0K | $77.0K | $110.0K | $22.0K | $34.0K | $110.0K | $18.0K | $7.0K | |||||||||||||||||
| Increase Decrease In Other Operating Assets | $0.00 | -$153.0K | $0.00 | -$7.0K | $25.0K | $23.0K | $25.0K | $0.00 | $10.0K | -$9.0K | $3.0K | $40.0K | -$76.0K | ||||||||||||||||||
| Increase Decrease In Inventories | -$605.0K | -$983.0K | -$558.0K | $163.0K | -$866.0K | -$1.3M | -$910.0K | -$590.0K | $1.5M | -$290.0K | -$257.0K | -$89.0K | $13.0K | $56.0K | |||||||||||||||||
| Increase Decrease In Accounts Receivable | $7.8M | $20.4M | $1.5M | -$447.0K | -$4.0M | $6.8M | $1.6M | $2.0M | -$646.0K | $531.0K | $967.0K | $494.0K | $586.0K | ||||||||||||||||||
| Proceeds From Issuance Or Sale Of Equity | $1.4M | $1.4M | $4.0M | $480.0K | $2.4M | $1.9M | $1.1M | $75.0K | $17.4M | $906.0K | $13.2M | ||||||||||||||||||||
| Increase Decrease In Other Accrued Liabilities | -$5.9M | $9.1M | $8.0M | $5.0M | -$3.2M | -$3.7M | -$5.0M | -$2.4M | $985.0K | $1.3M | $543.0K | ||||||||||||||||||||
| Adjustments Related To Tax Withholding For Share Based Compensation | $13.9M | $19.2M | $21.1M | $19.7M | $6.2M | $3.6M | $17.9M | $4.8M | $6.4M | $26.2M | $9.4M | $7.0M | $4.3M | $3.2M | $22.5M | $155.0K | $835.0K | $5.1M | |||||||||||||
| Payments To Acquire Marketable Securities | $115.1M | $77.9M | $0.00 | $92.6M | $127.4M | $48.5M | $70.9M | $50.9M | $19.3M | $0.00 | |||||||||||||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $15.8M | $1.8M | $1.2M | $1.9M | $2.3M | $1.6M | $16.4M | $100.0K | $0.00 | $4.2M | $0.00 | ||||||||||||||||||||
| Increase Decrease In Other Current Liabilities | $1.2M | -$6.0K | -$77.0K | $1.0M | $92.0K | -$260.0K | $137.0K | ||||||||||||||||||||||||
| Increase Decrease In Operating Lease Liability | -$101.0K | -$75.0K | -$568.0K | -$526.0K | -$484.0K | -$349.0K | -$357.0K | ||||||||||||||||||||||||
| Payments For Repurchase Of Common Stock | $27.4M | $476.0K | $0.00 | $0.00 | $33.5M | $275.0K | $13.6M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.82 | $1.23 | $0.94 | $0.87 | $0.89 | $0.85 | $0.77 | $0.60 | $1.04 | $0.07 | -$0.06 | -$0.31 | -$0.46 | -$0.41 | -$0.39 | -$0.38 | -$0.38 |
| Earnings Per Share Basic | $0.95 | $1.35 | $1.02 | $0.95 | $0.97 | $0.92 | $0.82 | $0.65 | $1.14 | $0.07 | $-0.06 | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 103.9M | 103.2M | 103.6M | 106.8M | 115.7M | 115.4M | 114.3M | 115.3M | 113.5M | 110.6M | 106.9M | 101.0M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 120.0M | 113.5M | 111.7M | 116.0M | 126.0M | 124.2M | 122.6M | 126.7M | 124.5M | 116.1M | 106.9M | 101.0M | |||||
| Common Stock Shares Authorized | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 140.0M | 140.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 106.0M | 105.1M | 103.4M | 107.8M | 105.9M | 116.7M | 114.5M | 115.0M | 114.7M | 112.7M | 109.6M | 101.4M | 99.8M | 99.8M | 84.2M | 72.4M | |
| Common Stock Shares Issued | 142.5M | 137.8M | 134.3M | 131.0M | 127.2M | 122.6M | 119.8M | 116.8M | 114.7M | 112.7M | 109.6M | 101.4M | 99.8M | 99.8M | 84.2M | 72.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.16 | $0.29 | $0.17 | $0.41 | $0.32 | $0.25 | $0.28 | $0.25 | $0.14 | $0.30 | $0.24 | $0.20 | $0.24 | $0.21 | $0.18 | $0.20 | $0.17 | $0.23 | $0.25 | $0.24 | $0.22 | $0.17 | $0.15 | $0.18 | $0.14 | $0.14 | $0.14 | $0.77 | $0.11 | $0.10 | $0.04 | $0.04 | $0.02 | $0.01 | $0.00 | $0.01 | -$0.01 | -$0.02 | -$0.05 | -$0.04 | -$0.06 | -$0.07 | -$0.14 | -$0.11 | -$0.11 | -$0.12 | -$0.12 | -$0.11 | -$0.08 | -$0.09 | -$0.13 | -$0.12 | -$0.08 | -$0.11 | -$0.09 | -$0.10 | -$0.09 |
| Earnings Per Share Basic | $0.19 | $0.33 | $0.19 | $0.45 | $0.34 | $0.27 | $0.31 | $0.27 | $0.15 | $0.32 | $0.26 | $0.22 | $0.26 | $0.23 | $0.20 | $0.22 | $0.19 | $0.25 | $0.26 | $0.26 | $0.23 | $0.18 | $0.16 | $0.19 | $0.15 | $0.16 | $0.15 | $0.86 | $0.12 | $0.11 | $0.04 | $0.02 | $0.01 | ||||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 103.5M | 104.1M | 104.1M | 103.4M | 103.1M | 102.8M | 102.0M | 102.0M | 107.9M | 107.1M | 106.3M | 106.0M | 115.8M | 116.3M | 116.8M | 115.7M | 115.0M | 114.6M | 113.9M | 114.3M | 114.8M | 115.8M | 115.5M | 114.9M | 113.6M | 113.2M | 112.9M | 110.7M | 110.0M | 109.7M | 108.5M | 107.9M | |||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 119.4M | 120.5M | 119.8M | 113.7M | 111.2M | 109.9M | 111.1M | 109.6M | 115.4M | 116.6M | 115.4M | 115.0M | 125.1M | 126.7M | 129.7M | 124.5M | 123.2M | 122.2M | 121.8M | 121.8M | 123.9M | 126.2M | 127.5M | 127.7M | 125.7M | 123.0M | 121.2M | 116.4M | 115.3M | 109.7M | 108.5M | 107.9M | |||||||||||||||||||||||||
| Common Stock Shares Authorized | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | 280.0M | ||||||||||||||||||||||||||||||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||||||||
| Common Stock Shares Outstanding | 114.1M | 113.4M | 113.1M | 110.9M | 110.5M | 109.7M | 108.7M | 108.2M | 107.7M | 101.1M | 101.1M | 100.7M | 99.8M | 99.8M | 99.8M | ||||||||||||||||||||||||||||||||||||||||||
| Common Stock Shares Issued | 114.1M | 113.4M | 113.1M | 110.9M | 110.5M | 109.7M | 108.7M | 108.2M | 107.7M | 101.1M | 101.1M | 100.7M | 99.8M | 99.8M | 99.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $716.6M | $538.1M | $375.1M | $289.2M | $241.5M | $225.7M | $194.9M | $161.8M | $106.3M | $71.1M | $53.7M | $54.2M | $51.9M | ||||||||
| Stock Issued During Period Value Stock Options Exercised | $50.0M | $30.8M | $29.1M | $28.5M | $32.0M | $25.3M | $10.4M | $9.3M | $7.2M | $7.7M | $5.2M | $1.8M | $55.0K | $289.0K | $371.0K | $151.0K | $4.0K | $21.0K | $19.0K | $1.0K | $1.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $76.5M | $55.7M | $46.0M | $42.5M | $43.2M | ||||||||||||||||
| Accretion Expense | $456.0K | $1.9M | $2.8M | $3.7M | $4.4M | $1.7M | |||||||||||||||
| Additional Paid In Capital | $832.1M | $738.5M | $662.3M | $591.3M | $516.1M | $457.1M | $417.2M | $384.1M | $363.5M | $348.8M | $320.5M | $313.5M | $308.3M | $243.3M | $197.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $197.4M | $167.8M | $153.8M | $135.9M | $128.2M | $117.3M | $92.4M | $88.1M | $90.8M | $69.8M | $72.0M | $66.9M | $59.9M | $59.6M | $59.8M | $61.6M | $53.3M | $55.5M | $48.5M | $47.6M | $45.9M | $41.5M | $41.7M | $36.7M | $29.1M | $22.8M | $22.9M | $18.7M | $18.2M | $15.5M | $13.2M | $13.1M | $14.1M | |||||||||||
| Stock Issued During Period Value Stock Options Exercised | $9.9M | $15.1M | $12.9M | $10.3M | $7.6M | $3.5M | $14.0M | $4.5M | $6.5M | $12.2M | $6.6M | $6.5M | $6.2M | $6.7M | $10.1M | $6.0M | $7.6M | $480.0K | $2.7M | $1.5M | $3.4M | $634.0K | $4.0M | $1.9M | ||||||||||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $20.4M | $19.4M | $15.7M | $14.3M | $13.9M | $12.9M | $11.7M | $11.4M | $11.0M | $10.6M | $10.7M | $10.8M | $11.0M | $11.1M | $10.1M | $8.8M | $8.5M | $8.0M | $7.3M | $7.8M | $6.7M | $6.5M | $6.0M | $5.0M | ||||||||||||||||||||
| Accretion Expense | $37.0K | $149.0K | $270.0K | $455.0K | $523.0K | $584.0K | $698.0K | $737.0K | $762.0K | $895.0K | $935.0K | $1.0M | $1.1M | $1.1M | $1.1M | |||||||||||||||||||||||||||||
| Additional Paid In Capital | $377.7M | $371.3M | $367.4M | $358.0M | $355.0M | $350.5M | $344.7M | $342.2M | $339.3M | $318.7M | $317.4M | $315.8M | $312.2M | $310.9M | $309.6M | $307.0M | $259.9M | $258.8M | $242.2M | $241.0M |
Most recent annual filing with the SEC: February 24, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.